About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6231210
Allelic
Composition
Tg(H2-K-Hmga1)#Lmsr/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die between 1 and 8.5 months of age, with a mean age of death of 4.8 +/- 2.6 months

growth/size/body
• mice develop organomegaly and die between 1 and 8.5 months of age

neoplasm
• all females have leukemia and/or lymphoma at the time of death
• presence of abnormal lymphoblasts in the bone marrow, spleen, and peripheral blood in most mice, suggesting a leukemia-like process
• abnormal lymphoblasts are also are seen in the liver, kidneys, and lungs
• tumors express T-cell markers
• all mice have at least 2 organs affected, with most showing multiorgan involvement
• all mice develop lymphoid malignancy at a mean age of 9.6 +/- 2.4 months (J:90252)
• all mice show lymphoma in the spleen (J:90252)
• 20 of 23 mice show lymphoma in the thymus (J:90252)
• 21 of 23 mice show lymphoma in the bone marrow (J:90252)
• 21 of 24 mice show lymphoma in the lymph nodes (J:90252)
• 18 of 23 mice show gut-associated lymphoid tissue (J:90252)
• all females have leukemia and/or lymphoma at the time of death (J:121308)
• by 2 months of age, uteri are abnormal with mild enlargement and development of early adenosarcoma-like changes which progress to fully developed tumors by 6-12 months of age
• all female founders develop uterine tumors at a mean age of 4.2 +/- 0.6 months
• all third generation females develop uterine tumors at a mean age of 8.1 +/- 2.4 months
• uteri show large, polypoid intracavitary endometrial tumors resembling human uterine adenosarcomas
• tumors are comprised of an overgrowth of endometrial stroma accompanied by benign-appearing endometrial type glands
• however, no metastatic uterine tumors are seen
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas

muscle
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas

behavior/neurological
• mice show decreased activity with disease progression

digestive/alimentary system
• intestines are hyperemic with a thickened mucosa and increased weight at necropsy
• both large and small intestines exhibit increased proliferation, ectopic crypt formation, and polyp formation
• 4 mice develop rectal or cervical prolapse
• polyp formation in both large and small intestines

hematopoietic system
• blood counts show a pronounced leukocytosis

immune system
• blood counts show a pronounced leukocytosis

reproductive system
• by 2 months of age, uteri are abnormal with mild enlargement and development of early adenosarcoma-like changes which progress to fully developed tumors by 6-12 months of age
• all female founders develop uterine tumors at a mean age of 4.2 +/- 0.6 months
• all third generation females develop uterine tumors at a mean age of 8.1 +/- 2.4 months
• uteri show large, polypoid intracavitary endometrial tumors resembling human uterine adenosarcomas
• tumors are comprised of an overgrowth of endometrial stroma accompanied by benign-appearing endometrial type glands
• however, no metastatic uterine tumors are seen
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas
• endometrial stroma has greatly increased volume with variable degrees of hypercellularity and edema and the epithelial component shows foci of glandular crowding and dilation
• 4 mice develop rectal or cervical prolapse
• all females are infertile
• however, males exhibit normal fertility


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory